Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries

Mayo Clin Proc. 2020 Dec;95(12):2606-2608. doi: 10.1016/j.mayocp.2020.10.007. Epub 2020 Oct 15.

Authors

Shahrukh K Hashmi¹, M Hassan Murad², Elitza S Theel³

Affiliations

¹ Department of Internal Medicine, Mayo Clinic, Rochester, MN; Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates. Electronic address: hashmi.shahrukh@mayo.edu.
² Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
³ Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

No abstract available

Publication types

Review

MeSH terms

COVID-19 / diagnosis*
COVID-19 Nucleic Acid Testing / standards*
COVID-19 Serological Testing / standards*
Developing Countries
Health Policy
Humans
Mass Screening / methods*
Pandemics
SARS-CoV-2